REQUEST A DEMO
Total
USD $0.00
Search more companies

Ilender Peru S.A. (Peru)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Ilender Peru S.A. Profile Updated: October 31, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Ilender Peru S.A is a company belonging to the Multinational Corporation Ilender, whose purpose is to achieve excellence in the development, production and marketing of veterinary medicinal products. It was founded in Lima, Peru on August 10, 1989, operating successfully in the markets of Bolivia, Brazil, Chile, Colombia, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Panama, Paraguay and Venezuela.

Ilender Peru exports part of its production to Brazil, Colombia, Venezuela and Bolivia.

Headquarters
Av. Manuel Olguin 373, Of. 102, Santiago De Surco
Lima; Lima;

Contact Details: Purchase the Ilender Peru S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Ilender Peru S.A. report to view the information.
Outstanding Shares:
Purchase the Ilender Peru S.A. report to view the information.
Incorporation Date:
August 10, 1989
Key Executives
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Executive Director
Purchase this report to view the information.
Financial and Administrative Manager
Purchase this report to view the information.
Human Resources Manager
Purchase this report to view the information.
Sales Director
Ownership Details
Purchase this report to view the information.
90%
Company Performance
Financial values in the chart are available after Ilender Peru S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PEN. Absolute financial data is included in the purchased report.
Total operating revenue
23.87%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?